We leveraged the tNM AML model to investigate potential mechanisms of relapse after targeting the Ras oncogene in AML.8 In this system, suppression of NRAS(V12) expression resulted in rapid leukemia regression (Figure 1). The gene discussed is NRAS; the disease is acute myeloid leukemia.